CerviLenz (Chagrin Falls, OH) a commercial-stage developer of a diagnostic single-use medical device for measuring cervical length to determine the risk of pre-term birth in pregnant women, closed a $4M Series A financing. Participants include Arboretum Ventures and Chrysalis Ventures.